A Good Time to Have Bad Asthma

Recent Learnings in Asthma Immunology

Learning Objectives

  • Review the evidence around targeting airway inflammation in asthma
  • Explore the current framework of severe asthma management to achieve transformational patient outcomes
Write your awesome label here.


Write your awesome label here.

Dr. David Jackson, MBBS MRCP MSc PhD

Guy’s and St Thomas’ NHS Foundation Trust, and King’s College London
David Jackson is an Associate Professor in Respiratory Medicine at King’s College London and Clinical Lead for the Severe Asthma and Eosinophilic Lung Disease Service at Guy’s and St Thomas’ Hospitals in London. This is the largest unit of its kind in the UK reviewing over 200 patients/ week.

Dr Jackson has an MSc in Allergy and a PhD in the pathophysiology of asthma exacerbations and has published widely in the field of type 2 immunity, biologic therapies in asthma, and the mechanisms of virus-induced asthma exacerbations.

He is a current member of the BTS Asthma advisory group and is on the steering committee of the International Severe Asthma Registry. He is an Associate Editor at the journals THORAX and ALLERGY, the Reviews Editor at CHEST, and was the editor of the ERS Monograph book on Eosinophilic Lung Diseases.